What is the recommended prescription treatment for a 13-year-old with itchy hives (urticaria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescription Treatment for a 13-Year-Old with Itchy Hives

Start with a second-generation non-sedating H1 antihistamine such as cetirizine 10 mg once daily or loratadine 10 mg once daily as first-line therapy for urticaria in this adolescent patient. 1, 2, 3

First-Line Treatment: Non-Sedating Antihistamines

  • Prescribe one of the following second-generation H1 antihistamines at standard dosing: 1, 2, 3

    • Cetirizine 10 mg once daily
    • Loratadine 10 mg once daily 4
    • Desloratadine 5 mg once daily
    • Fexofenadine 180 mg once daily
    • Levocetirizine 5 mg once daily
  • Offer the patient a choice between at least two different antihistamines, as individual responses and tolerance vary significantly between agents 1, 2, 3

  • Cetirizine has the shortest time to reach maximum concentration, making it advantageous for rapid symptom relief 2

  • Avoid first-generation antihistamines (diphenhydramine, hydroxyzine) as primary therapy due to significant sedation and anticholinergic effects, though they may be added at bedtime if additional symptom control is needed 3, 5

Dose Escalation Strategy

  • If symptoms are not adequately controlled after 2-4 weeks at standard dosing, increase the antihistamine dose up to 4 times the standard dose 1, 2, 3, 6

  • This approach (e.g., cetirizine 40 mg daily or loratadine 40 mg daily) improves symptoms in approximately 75% of patients with difficult-to-treat urticaria without compromising safety 6

  • Increasing antihistamine doses improves quality of life without increasing somnolence 6

Adjunctive Measures for Acute Management

  • For severe acute urticaria with inadequate response to antihistamines alone, consider a short course of oral corticosteroids (e.g., prednisolone 50 mg daily for 3 days, adjusted for pediatric weight) 2

  • Limit corticosteroids to 3-10 days only for severe acute exacerbations; long-term use should be avoided 2

  • Prescribe both antihistamines and an epinephrine autoinjector if there is any concern for potential anaphylaxis or severe angioedema involving the airway 7, 2

General Measures and Trigger Avoidance

  • Identify and minimize aggravating factors including overheating, stress, alcohol, aspirin, NSAIDs, and codeine 1, 2, 3

  • Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) can provide symptomatic relief 1, 2

  • Control environmental temperature through rational use of bathing, showering, swimming, and air conditioning to decrease mediator release and reduce the need for higher antihistamine doses 2

When to Refer or Escalate Treatment

  • If symptoms persist beyond 6 weeks despite high-dose antihistamines, the patient has chronic spontaneous urticaria and should be referred to an allergist or dermatologist 2, 3

  • Second-line therapy for chronic urticaria unresponsive to quadrupled antihistamine doses is omalizumab 300 mg subcutaneously every 4 weeks 1, 2, 3

  • Third-line therapy is cyclosporine 4 mg/kg daily for up to 2 months, reserved for specialist management 1, 2, 3

Important Caveats

  • Do not perform extensive laboratory testing for acute urticaria; testing is only indicated if symptoms persist beyond 6 weeks or if specific systemic disease is suspected based on history and physical examination 2, 3

  • Approximately 50% of patients with chronic urticaria presenting with only hives will be symptom-free within 6 months 2

  • Antihistamines should be used for mild symptoms (a few hives, mild discomfort), while epinephrine is reserved for severe symptoms including diffuse hives, respiratory symptoms, or angioedema affecting breathing 7

References

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Urticaria in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.